Mirikizumab Beats Placebo, Secukinumab for Psoriasis ...Middle East

Medscape - News
52-week trial data pitting an interleukin-23 drug against an IL-17 inhibitor and placebo offers insight on efficacy and safety. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirikizumab Beats Placebo, Secukinumab for Psoriasis )

Apple Storegoogle play

Also on site :



Latest News